Back
Apellis Pharmaceuticals Stock Price Chart
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.
Sell
37
APLS
Apellis Pharmaceuticals
Last Price:
41.02
Seasonality Move:
5.93%
7 Day Trial
ALL ACCESS PASS
$
7
Forget AI THIS is Way Bigger
If you've never heard of "QaaS" technology you need to click here now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.04 | Buy |
| 20-day SMA: | 38.43 | Buy |
| 50-day SMA: | 37.98 | Buy |
| 200-day SMA: | 50.76 | Sell |
| 8-day EMA: | 39.27 | Buy |
| 20-day EMA: | 38.68 | Buy |
| 50-day EMA: | 39.03 | Buy |
| 200-day EMA: | 46.63 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 60.14 | Buy |
| Chaikin Money Flow: | 854085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.92 - 39.7) | Buy |
| Bollinger Bands (100): | (36.8 - 44.46) | Buy |
Apellis Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 41.05 while APLS 8-day simple moving average is 39.04, which is a Buy signal.
- The stock price of APLS is 41.05 while Apellis Pharmaceuticals 20-day SMA is 38.43, which makes it a Buy.
- Apellis Pharmaceuticals 50-day simple moving average is 37.98 while APLS share price is 41.05, making it a Buy technically.
- APLS stock price is 41.05 and Apellis Pharmaceuticals 200-day simple moving average is 50.76, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
37
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $41.05. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
5B
Price in USD:
41.05
Share Volume:
1.79M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
33.49
Sell
37
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 41.05 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 41.05 while APLS 8-day exponential moving average is 39.27, which is a Buy signal.
- The stock price of APLS is 41.05 while Apellis Pharmaceuticals 20-day EMA is 38.68, which makes it a Buy.
- Apellis Pharmaceuticals 50-day exponential moving average is 39.03 while APLS share price is 41.05, making it a Buy technically.
- APLS stock price is 41.05 and Apellis Pharmaceuticals 200-day simple moving average is 46.63, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting Apellis Pharmaceuticals is a Buy
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 60.14, which suggest Apellis Pharmaceuticals is overbought
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (35.92 - 39.7), which suggest Apellis Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (36.8 - 44.46), which suggest Apellis Pharmaceuticals is a Buy
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.